CMR Surgical has named Daniel (Dan) Moore as non-executive chairman of its board, effective immediately.

Moore boasts over 35 years of both executive and board leadership experience from global medtech companies, including Boston Scientific. He was most recently chairman at LivaNova.

Before the merger of Sorin and Cyberonics to create LivaNova, Moore was president and CEO of Cyberonics for eight years. He’s also served as chairman at Brainscope, GI Dynamics, and the Medical Device Manufacturers Association (MDMA). He also served on the Epilepsy Foundation’s board.

Moore established his career in medical devices at Boston Scientific, where he worked for almost two decades. There he had several senior executive roles, includes president of intercontinental and distribution management.

He will lead CMR Surgical’s board and work alongside board members and the executive leadership team as they aim to bring the Versius robotic surgical system to more hospitals around the world.

“Daniel has exceptional experience leading medical technology organizations, and a passion for how technology can help transform the lives of patients,” said CMR Surgical CEO Supratim Bose. “His significant sector experience, combined with his strong executive and board level leadership, will be invaluable to CMR as we continue to partner with more hospitals around the world, bringing the benefits of robotic-assisted surgery to more patients.”

“The surgical robotics sector is one of the most exciting in the medtech space and Versius is a truly differentiated technology with many large untapped markets yet to be reached, and more patients to be served,” added Moore. “I look forward to working with the Board, Supratim, and the leadership team to help realize the vision of the company and true promise of Versius.”

Earlier this year, CMR Surgical welcomed former Lumenis executive Shlomi Cohen as its new chief financial officer.